
The National Institute for Health and Care Excellence (NICE) greenlit the use of Veoza for women in the UK via the NHS this week.
Now authorised, it's thought that half a million women could benefit from the drug, also known as fezolinetant, where hormone replacement therapy (HRT) is not an option due to contraindication or preference. The 45mg tablet is taken once a day.